An increase in inflammatory molecules, like CD40L and MCP‐1, is linked to the later stages of atherosclerotic cerebrovascular disease and raises the likelihood of recurrent cardiovascular events in diabetic patients with stroke (Davì et al., 2009). Here, CD40LG is linked to cerebrovascular disorder.